Corcept (CORT) Up 15.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 08/31/19
Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s SyndromeGlobeNewsWire • 08/28/19
Corcept Therapeutics Inc. (CORT) CEO Joseph Belanoff on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/02/19
Corcept (CORT) Down 11.3% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 06/08/19
Corcept Therapeutics Inc. (CORT) CEO Joseph Belanoff on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/10/19
Corcept (CORT) Down 6.1% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/27/19